Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Welcure Drugs & Pharmaceuticals LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:524661NSE Symbol: Not ListedP/E(TTM):2.97
ISIN Demat:INE331C01017Div & Yield %:0EPS(TTM):2.46
Book Value(Rs):9.1175527Market Cap ( Cr.):82.25Face Value(Rs):10
    Change Company 

To,

The Members,

Welcure Drugs & Pharmaceuticals Ltd.

The Board hereby presents the 33rd Annual Report together with Audited Financial Statements comprising Balance Sheet, the statement of Profit and Loss (including other comprehensive income), the cash flow statement and the statement of changes in Equity of the Company and Auditors Report for the Financial Year ended 31st March, 2025 in terms of Section 134(3) of Companies Act, 2013.

FINANCIAL SUMMARY OF THE COMPANY

The performance of the Company for the financial year ended on 31st March, 2025 is summarized below:

Particulars Year Ended 31.03.2025 (Rupees In Lacs) Year Ended 31.03.2024 (Rupees In Lacs)
Income (Gross) 2645.99 9.390
Expenditure 2367.99 26.870
Profit/(Loss) before Exceptional and extraordinary Items and tax 278.01 (17.480)
Less:- Tax Expense Current Tax/Mat 61.00 -
Deferred Tax Adjustment-Cr/Dr) -
Tax Adjustments for Earlier Year
Profit/ (Loss) after Tax 217.01 (17.480)
EPS 0.36 (1.301)

MEETINGS OF THE BOARD & COMMITTEES

A tentative calendar of Meeting is prepared and circulated well in advance to the Directors. The intervening gap between the meetings was within the period prescribed under the Companies Act, 2013, Secretarial Standard - 1 and Listing Regulations.

During the year ended March 31, 2025, the Board met 14 times. The details of Board/committee meetings and the attendance of Directors are provided in the Corporate Governance Report, which forms a part of this Report.

Further, all the recommendations of Audit Committee were accepted by the Board of Directors.

33nd Annual General Meeting of the Company for the financial year 2024-25 will be held on 24th September, 2025

DIRECTORS RESPONSIBILITY STATEMENT

Pursuant to the requirements of Section 134(3) (c) of the Companies Act, 2013 with respect to Directors' Responsibility Statement, your Directors hereby confirm that:

a) In the preparation of the annual accounts, the applicable accounting standards had been followed along with proper explanation relating to material departures;

b) The directors had selected such accounting policies and applied them consistently and made judgments and estimates that are reasonable and prudent so as to give a true and fair view of the state of affairs of the Company at the end of the Financial year and of the profit and loss of the company for that period;

c) The directors had taken proper and sufficient care for the maintenance of adequate accounting records in accordance with the provisions of this Act for safeguarding the assets of the company and for preventing and detecting fraud and other irregularities;

d) The directors had prepared the annual accounts on a going concern basis;

e) The director had laid down internal financial controls to be followed by the company and that such internal financial controls are adequate and were operating effectively; for ensuring the orderly and efficient conduct of business, including adherence to company's policies, the safeguarding its assets, prevention and detention of frauds and errors, the accuracy and completeness of accounting records, and the timely preparation of reliable financial information.

f) The directors had devised proper systems to ensure compliance with the provisions of all applicable laws and that such systems were adequate and operating effectively.

g) The Directors have devised proper systems to ensure compliance with the provisions of all applicable Secretarial Standards and that such systems are adequate and operating effectively.

DETAILS IN RESPECT OF FRAUD

In terms of provisions of section 134(3) (ca) no fraud was reported by auditors under section 143(12) of the Companies Act, 2013.

ISSUE OF SECURITIES ON PREFERENTIAL BASIS

> The Board of Directors at its meeting held on June 10, 2024 approved the Preferential Allotment of upto 9,90,00,000 (Nine Crores Ninety Lakhs Only) fully Convertible Warrants to the persons belonging to Non promoter, Public Category.

> On July 11, 2024 the Shareholders approved the Preferential Allotment of upto 9,90,00,000 (Nine Crores Ninety Lakhs Only) fully Convertible Warrants to the persons belonging to Non promoter, Public Category, by passing Special Resolution through postal ballot.

> The Board of Directors at its meeting held on July 18, 2024 approved the Allotment of 9,90,00,000 Fully Convertible Warrants at Issue Price of Rs. 10/- on preferential basis.

> The Board of Directors at its meeting held on July 24, 2024 approved the Conversion of 3,30,00,000 warrants into equal number of equity shares of the Company on preferential basis.

> The Board of Directors at its meeting held on August 08, 2024 approved the Conversion of 3,29,99,997 warrants into equal number of equity shares of the Company on preferential basis"

> The Board of Directors at its meeting held on August 14, 2024 approved the Conversion of 3,30,00,006 warrants into equal number of equity shares of the Company on preferential basis.

FORFEITURE OF PARTLY PAID UP EQUITY SHARES

The Board of Directors at its meeting held on , i.e., 21st October 2024 approved the forfeiture of 1,53,900 partly paid-up equity shares on which holders thereof have failed to pay the balance call money of Rs.5.00/- per share.

On 30th April 2025 BSE approved the forfeiture of 1,53,900 partly paid-up equity shares on which holders thereof have failed to pay the balance call money of Rs.5.00/- per share.

STATEMENT OF DECLARATION BY INDEPENDENT DIRECTORS

All Independent Directors have given declaration that they meet the criteria of independence as provided under Section 149 of the Act and Regulation 16(1) (b) of the Listing Regulations (including any statutory modification(s) or re-enactment(s) thereof for the time being in force). The Independent Directors have also confirmed that they have complied with the Company's code of conduct.

AUDIT OBSERVATIONS

(i) Statutory Auditor:

Disclaimer of Opinion

The Statutory Auditor have given the following Disclaimer of Opinions which are as follows

Disclaimer of Opinion Management Response
a. List of Audit Qualification: The company has unsecured loans amounting to Rs8472.96 Lacs. Management has not charged interest on these loans, and relevant agreements along with cross-confirmations are not available. In the absence of valid agreements and necessary confirmations, the accuracy of the balances and their interest-free status could not be verified, potentially impacting the fair presentation of liabilities and interest expenses. On account of no impact on figures, adjustments to be required for each qualification.
Balance of GST Credit receivable Rs4.65 Lacs pending for GST reconciliation. Reconciliation with the GST Online Portal has not been provided, affecting the accuracy of GST Input Credit and the liability towards the government.
The company has trade payables amounting to Rs289.76 Lacs; however, the supporting for bifurcation of Micro, Small, and Medium Enterprises (MSME) creditors has not been provided. Non-disclosure of MSME classification contravenes the Micro, Small and Medium Enterprises Development (MSMED) Act, 2006, impacting regulatory compliance and financial transparency.
Advances to suppliers of Rs1,943.84 Lacs remain unconfirmed. Absence of confirmations from these suppliers affects the reliability of liabilities disclosed in the financial statements.
A borrowings amounting to Rs12,319.89 Lacs remains unconfirmed to certain parties. The absence of loan confirmations impacts the reliability of Borrowings and financial disclosures.
We are in receipt of certain sales invoices; however, they are not supported with E-Way bills, Delivery Challans, or Transportation details. In the absence of these critical documents, we are unable to verify the genuineness of the transactions.
The Company has not maintained Goods Inward Reports with respect to purchases, nor does it own or lease any warehouse or godown facility. Management has represented that goods are traded directly from vendors to customers without being stored by the Company. However, in the absence of documentary evidence, we are unable to verify the accuracy of this assertion. Furthermore, inventory as at 31st March 2025 stands at Rs1,43,52.36 Lacs and we were unable to obtain sufficient appropriate audit evidence to confirm the existence and valuation of the same.

. SECRETARIAL AUDITOR:

No qualifications, reservation or adverse remarks or disclaimer was made by the secretarial auditor in his audit report.

LOANS, GUARANTEES AND INVESTMENTS:

The Company has given Loan or Guarantee or made Investment under Section 186 within the limits specified under Sec 186(2) of the Companies Act 2013.

PARTICULARS OF CONTRACTS OR ARRANGEMENTS WITH THE RELATED PARTIES:

The following related party transaction has taken place during the financial year 2024-25;

List of related parties with whom transactions have taken place
S.No. Name Of Related Party Relation Nature Of Transaction F.Y 2024-2025 (From 01.04.2024 to 31.03.2025)
1. Mr. Manowar Ali Company Secretary Remuneration 1,65,000
2. Mr. Altaf Hussain Shah Managing Director and CFO Remuneration 9,30,000
3. Mr. Suraj Chagan Solanki Director Remuneration 8,65,000

STATE OF AFFAIRS- AUDITED IND AS FINANCIAL STATEMENTS

During the Financial Year 2024-25, the total revenue (including other income) was Rs. 2645.99 Lacs, (Rs. 9.390 Lacs in the previous year), and had a Net Profit after tax of Rs. 217.01 Lacs, as against the Net loss of Rs. (17.480) Lacs previous year.

i) Reserves

The net profit after tax of Rs. 217.01 Lacs have been retained in the profit & loss account and has been carried forward to the Balance sheet accordingly.

ii) Dividend

Further, no dividend was proposed to be declared during the period under review. MATERIAL CHANGES AND COMMITMENTS

Subsequent to the end of the financial year i.e. 31st March 2025 and up to the date of this Report, the following material changes and commitments have occurred which have an impact on the financial position of the Company

A. The Board of Directors at its meeting held, on 21st October 2024 approved the forfeiture of 1,53,900 partly paid-up equity shares on which holders thereof have failed to pay the balance call money of Rs.5.00/- per share.

Further, BSE via Approval letter dated April 30, 2025 approved the forfeiture of 1,53,900 equity shares of Rs. 10/- each, which were partly paid-up due to non-payment of allotment/call monies.

B. The Board of Directors at their meeting held i.e., Wednesday, 14th May, 2025 at the registered office of the Company Approved the Alteration in Main Objects Clause of Memorandum of Association of the Company by addition of New Objects.

C. The Board of Directors at their meeting held i.e., Wednesday,14th May, 2025 at the registered office of the Company approved the increase in the Authorised Share Capital of the Company from Rs. 1,16,00,00,000 (Rupees One Hundred Sixteen Crores Only) divided into 11,60,00,000 (Eleven Crore Sixty Lakhs) Equity Shares of Rs. 10/- each to Rs. 1,86,00,00,000 (Rupees One Hundred Eighty Six Crore Only) divided into 18,60,00,000 (Rupees Eighteen Crore Sixty Lakhs Only) Equity Shares of Rs. 10/- each and consequent amendment in the Capital Clause (Clause V) of Memorandum of Association of the Company.

D. The Board of director, on June 18th 2025, has executed a definitive mandate for third- party sourcing and procurement services aggregating ~Rs517 crore with an overseas client, Fortune Sagar Impex Company Limited, Thailand.

E. Company on 30th June,2025 wins new Rs 856 million export-sourcing orders from Giant Exim & Ravina International.

F. Company on 08th July,2025 has successfully completed all export-sourcing assignments concluded during Q1 FY 2025-26 orders aggregating Rs 299.91 crore.

G. Company on 05th August, 2025 shifted its Corporate Office from 107/22 Gali No 3, East Azad Nagar, Shahdara, Delhi - 110051 to 608, 6th Floor, Shree Balaji Hights, B/S.

I.D.B.I. Bank, NR. Bodyline Cross Road, C. G. Road, Ellisbridge, Ahmedabad-380006, Gujarat - 380051.

CONSERVATION OF ENERGY, TECHNOLOGY ABSORPTION AND FOREIGN

EXCHANGE EARNINGS AND OUTGO:

a. Conservation of energy:

Company has no manufacturing operations; therefore, provisions relating to disclosure of

conservation of energy are not applicable to the Company.

b. Technology absorption:

During the year under review no new technology was absorbed and no expenditure was

incurred on Research & Development.

c. Foreign exchange earnings and outgo:

Foreign exchange earnings and outgo were nil during the current year.

RISK MANAGEMENT

The Company has well defined process to ensure risks are identified and steps to treat them are put in place at the right level in the management. The operating managers are responsible for identifying and putting in place mitigation plan for operational and process risks. Key strategic and business risks are identified and managed by the Directors in the organization.

The Company's approach to addressing business risks is comprehensive and includes periodic review of such risks and has established a framework for mitigating controls and reporting mechanism of such risks. Some of the risks that the Company is exposed to are: (i) Financial Risk (ii) Regulatory Risks (iii) Human Resources Risks (iv) Strategic Risks.

CORPORATE SOCIAL RESPONSIBILITY

During the year under review, the Net Worth of the Company is less than Rs. 500.00 crore; turnover is less than Rs.1000.00 crore; and net profit is less than Rs. 5.00 crore; therefore constitution of corporate Social Responsibility Committee is not applicable in terms of section 135(1) of the Companies Act, 2013.

BOARD EVALUATION

Pursuant to the provisions of the Companies Act, 2013 read with the Rules issued thereunder, Regulation 17(10) of the Listing Regulations and the circular issued by SEBI dated 5th January, 2017 with respect to Guidance Note on Board Evaluation, the evaluation of the annual performance of the Directors/Board/Committees was carried out for the Financial Year 2024-25. A statement on annual evaluation by the Board of its performance and performance of its Committees as well as Individual Directors forms part of the Corporate Governance Report.

CHANGE IN NATURE OF BUSINESS

During the year under review, there has been no change in the nature of business of the Company.

DIRECTORS AND KEY MANAGERIAL PERSONNEL

The Company has a professional Board with Executive Directors & Non-Executive Directors who bring the right mix of knowledge, skills, and expertise and help the Company in implementing the best Corporate Governance practices.

a) Retirement by Rotation

Pursuant to the provisions of Section 152 and other applicable provisions of the Companies Act, 2013, One- third of such of the Directors as are liable to retire by rotation, shall retire every year and, if eligible, offer themselves for re-appointment at every AGM. Consequently, Mr. Ravi Thakor (DIN 11210729), Director, is liable to retire by rotation at the ensuing Annual General Meeting of the Company and being eligible, he has offered himself for re-appointment. Necessary resolution for his re-appointment is included in the Notice of AGM for seeking approval of members. The Board of Directors has recommended his re-appointment.

The details as required under Regulation 36(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 regarding re-appointment of Mr. Ravi Thakor his brief resume, the nature of expertise in specific functional areas, names of Companies

in which he hold Directorships, committee Memberships/ Chairmanships, his shareholding

in the Company etc., are furnished in the annexure to the notice of the ensuing AGM.

b) Appointment

1. Mr. Altaf Hussain Shah

• Mr. Altaf Hussain Shah (DIN:10351528) The Board of Directors of Company based on the recommendation of the Nomination and Remuneration Committee has appointed Mr. Altaf Hussain Shah (DIN:10351528) as an Managing Director of the Company with effect from 28th march, 2024 subject to Shareholders' Approval.

• The above mentioned appointment has been approved by the shareholders by passing Ordinary Resolution through Postal Ballot as on 02nd May, 2024.

2. Ms. Deepika Krishnan Iyer

• The appointment of Ms. Deepika Krishnan Iyer (DIN: 10515778) as a NonExecutive Independent Director of the Company has been approved by the shareholders by passing Special Resolution through Postal Ballot as on 02nd May, 2024.

3. Mr. Ashish Abbi

• The appointment of Mr. Ashish Abbi (DIN: 10515790) as Non-Executive Independent Director of the Company has been approved by the shareholders by passing Special Resolution through Postal Ballot as on 02nd May, 2024.

4. Mr. Pradeep Dnyaneshwar Terse

• The Board of Directors of Company based on the recommendation of the Nomination and Remuneration Committee has appointed Mr. Pradeep Dnyaneshwar Terse (DIN 10758084) as an Additional Non- Executive Independent Director of the Company for a period of 5 years with effect from 04th October, 2024 subject to Shareholders' Approval.

The above mentioned appointment has been approved by the shareholders by passing Special Resolution through Postal Ballot as on 24th February, 2025.

5. Mr. Chintan Didawala

• The Board considered the recommendation of nomination committee and approved the appointment of Mr. Chintan Didawala (DIN: 11088268) as Additional Executive Director with effect from 6th May 2025.

• The Board considered and approved the appointment of Mr. Chintan Didawala (DIN: 11088268) as Chief Financial Officer of the company w.e.f 06th May, 2025.

• The Board considered the recommendation of nomination committee and approved the appointment of Mr. Chintan Didawala (DIN: 11088268) as Managing Director with effect from 14th May, 2025, subject to the approval of shareholders of the Company.

• The above mentioned appointment has been approved by the shareholders by passing Special Resolution through Postal Ballot as on 14th June, 2025.

6. Mr. Yogeshkumar Prajapati

• The Board of Directors of Company based on the recommendation of the Nomination and Remuneration Committee has appointed Mr. Yogeshkumar Prajapati (DIN 11210767) as Additional Non-Executive Independent Director of the Company with effect from August, 05th 2025 subject to Shareholders' Approval.

7. Mrs. Bhumika Pradhan

• The Board of Directors of Company based on the recommendation of the Nomination and Remuneration Committee has appointed Mrs. Bhumika Pradhan (DIN 10167275) as Additional Non-Executive Independent Director of the Company with effect from August, 05th 2025 subject to Shareholders' Approval.

8. Mr. Ravi Thakor

• The Board of Directors of Company based on the recommendation of the Nomination and Remuneration Committee has appointed Mr. Ravi Thakor (DIN 11210729) as Additional Non-Executive Non-Independent Director of the Company with effect from August, 05th 2025 subject to Shareholders' Approval.

c) Cessation

1) Mr. Altaf Hussain

• The Board received the resignation of Mr. Altaf Hussain (DIN: 10351528) on 5th May 2025 and board considered and accepted the Resignation of Mr. Altaf Hussain from the post of Managing Director- Executive Director & Chief Financial Officer of the company with effect from 5 th May 2025.

2) Mrs. Deepika Krishnan Iyer

• Board received the resignation of Mrs. Deepika Krishnan Iyer on 05th August, 2025 and board considered and accepted the Resignation of Mrs. Deepika Krishnan Iyer from the post of Non- Executive Independent Director of the company with effect from 06th August, 2025.

3) Mr. Ashish Abbi

• Board received the resignation of Mr. Ashish Abbi on 04th October 2024 and board considered and accepted the Resignation of Mr. Ashish Abbi from the post of Non- Executive Independent Director of the company with effect from 04" October 2024.

4) MR. Suraj Chagan Solanki

• Board received the resignation of Mr. Suraj Chagan Solanki on 05th August, 2025 and board considered and accepted the Resignation of Mr. Suraj Chagan Solanki

from the post of Non-executive Non-Independent director of the company with effect from 06th August, 2025.

Woman Director

• In terms of Section 149 of the Companies Act, 2013 read with Companies (Appointment and Qualification of Directors) Rules, 2014 and Regulation 17 of the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, the Company has appointed Mrs. Bhumika Pradhan who is serving on the Board of the Company, since 2025.

CHANGE IN COMPANY SECRETARY & COMPLIANCE OFFICER

a) Cessation

• Board considered and approved the resignation of Mr. Manowar, as the Company Secretary and Compliance Officer (Key Managerial Personnel) of the Company with effect from 21st February, 2025.

b) Appointment

• Board considered and approved the appointment of Ms. Palak Jain, (M.No:- A76264) as the Company Secretary and Compliance Officer (Key Managerial Personnel) of the Company in terms of Section 203 of the Companies Act, 2013 read with regulation 6 of SEBI (Listing Obligation and Disclosure Requirement) 2015, with effect from 06th May, 2025.

BOARD MEETINGS

During the year under review, the Board met Twenty One (21) times.

The intervening gap between the Meetings was within the period prescribed under the Companies Act, 2013.

Board Meeting dates are finalized in consultation with all directors and agenda papers backed up by comprehensive notes and detailed background information are circulated well in advance before the date of the meeting thereby enabling the Board to take informed decisions.

Following is the attendance of each of the Directors at the Board Meetings held during the period under review:

S. No. Date of Meeting Total No of Directors as on date of meeting Attendance
No. of Directors attended % of Attendance
1 30-05-2024 4 4 100
2 10-06-2024 4 4 100
3 18-07-2024 4 4 100
4 24-07-2024 4 4 100
5 08-08-2024 4 4 100
6 14-08-2024 4 4 100
7 02-09-2024 4 2 100
8 04-10-2024 5 5 100
9 21-10-2024 4 4 100
10 14-11-2024 4 4 100
11 02-12-2024 4 4 100
12 22-01-2025 4 4 100
13 14-02-2025 4 4 100
14 21-02-2025 4 4 100

COMMITTEE MEETINGS

a. AUDIT COMMITTEE

The composition of the Audit Committee and terms of reference are in compliance with the provisions of Section 177 of the Act. All members of the Committee are financially literate and have accounting or related financial management expertise.

Composition of Audit Committee:

Name Category of Directorship Designation in Audit Committee No. of Meetings Attended
Ms. Deepika Krishnan Iyer Non-Executive & Independent Director Chairman 09
Ms. Suraj chagan solanki Non-Executive & Non Independent Director Member 09
Mr. Pradeep dnyaneshwar terse Non-Executive & Independent Director Member 03

> Pursuant to the resignation of Mr. Ashish Abbi on 04th October, 2024, Committee was reconstituted.

> Pursuant to the resignation of Mr. Altaf hussain Shah on 01st April, 2024,

Committee was reconstituted.

During the year under review, the Audit Committee met 9 (Nine) times.

Following is the detail of the attendance of each of the members of the Audit Committee at its Meeting held during the year under review:

Date Total Number of Directors in the Committee as on date of the meeting Number of Directors Present (All directors including Independent director) No. of Independent Directors attending the meeting
30-May-2024 3 3 2
10-Jun-2024 3 3 2
18-Jul-2024 3 3 2
24-Jul-2024 3 3 2
8-Aug-2024 3 3 2
14-Aug-2024 3 3 2
21-Oct-2024 3 3 2
14-Nov-2024 4 4 3
14-Feb-2025 3 3 2

b. Nomination and Remuneration Committee

The composition of the Nomination and Remuneration Committee and terms of reference are in compliance with the provisions of Section 178 of the Act.

a. Composition of Nomination & Remuneration Committee as on March 31,2025:

Name Category of Directorship Designation in Audit Committee
Ms. Deepika Krishnan Iyer Non-Executive & Independent Director Chairman
Mr. Suraj Chagan Solanki Non-Executive & Non Independent Director Member
Mr. Pradeep Dnyaneshwar Non-Executive & Independent Member
Terse Director

> Pursuant to the resignation of Mr. Ashish Abbi on 04th October, 2024, Committee was reconstituted.

> Pursuant to the resignation of Mr. Altaf hussain Shah on 05th May, 2024, Committee was reconstituted.

During the year under review, the Nomination and Remuneration Committee met 7 (Seven) times.

Following is the detail of the attendance of each of the members of the Nomination and Remuneration Committee at its Meeting held during the year under review:

Date Total Number of Directors in the Committee as on date of the meeting Number of Directors Present (All directors including Independent director) No. of Independent Directors attending the meeting
30-May-24 3 3 3
10-Jun-24 3 3 3
14-Aug-24 3 3 2
04-Oct-24 3 3 2
02-Dec-24 3 3 2
22-Jan-2025 3 3 2
21-Feb-2025 3 3 2

c. Stakeholders Relationship Committee

The composition of the Stakeholders Relationship Committee and terms of reference are in compliance with the provisions of Section 178 of the Act.

Composition of Stakeholders' Relationship Committee as on March 31,2025:

Name Category of Directorship Designation in Audit Committee
Ms. Deepika Krishnan Iyer Non-Executive & Independent Director Chairman
Mr. Altaf Hussain Shah Executive Director Member
Mr. Pradeep dnyaneshwar terse Non-Executive & Independent Director Member

> Pursuant to the resignation of Mr. Ashish Abbi on 04th October, 2024, Committee was reconstituted.

During the year 2024-25, the Committee met on 30-May-24, 10-Jun-2024, 14-Aug-2024 and 14-Nov-2024.

SUBSIDIARIES, JOINT VENTURES OR ASSOCIATE COMPANIES

During the period under review no Company became or ceased to be its subsidiaries, joint venture or associate company.

FIXED DEPOSITS UNDER CHAPTER V

The Company has not accepted any deposit from its Directors, employees or general public during the year; and there is no unpaid or unclaimed deposit at the end of the year.

MATERIAL COURT ORDERS PASSED

During the year no material order was passed by any regulators, tribunals or courts which impacts the going concern & company's operations in future.

INTERNAL FINANCIAL CONTROL

According to Section 134(5)(e) of the Companies Act, 2013 read with rule 8 of the Companies (Accounts) Rules, 2014, the term Internal Financial Control(IFC) means the policies and procedures adopted by the Company for ensuring the orderly and efficient conduct of its business, including adherence to Company's policies, the safeguarding of its assets, the prevention and detection of frauds and errors, the accuracy and completeness of the accounting records, and the timely preparation of reliable financial information.

The Company believes that a strong internal control framework is very much essential and is part of good corporate governance practices. Your Company has in place well defined and adequate internal financial control framework commensurate with the size and complexity of its business to ensure proper recording of financial &operational information, compliance of various internal control and other regulatory/statutory compliances. All internal Audit findings and control systems are periodically reviewed by the Audit Committee of the Board of Directors, which provides strategic guidance on internal control.

SEXUAL HARASSMENT OF WOMAN AT WORK PLACE

The Company has zero tolerance for sexual harassment at workplace and had in place policy on Prevention, Prohibition and Redressal of Sexual Harassment for women at workplace in accordance with the requirements of Sexual Harassment of Women at Workplace (Prevention, Prohibition & Redressal) Act, 2013 (‘POSH Act') and Rules made thereunder.

As per the requirement of the Sexual Harassment of Women at Workplace (Prevention, Prohibition & Redressal) Act, 2013(POSH Act) and Rules made thereunder, the Company has constituted Internal Committees (IC). Our POSH Policy is now inclusive and gender neutral, detailing the governance mechanisms for prevention of sexual harassment issues relating to employees across genders including employees who identify themselves with LGBTQI+ community. During the year, company has not received any sexual harassment complaints.

To build awareness in this area, the Company has been conducting induction/refresher programmes in the organisation on a continuous basis. During the year, your Company organised offline training sessions on the topics of Gender Sensitisation and Code Policies including POSH for all office and factory-based employees.

During the year under review, no complaint pertaining to sexual harassment at work place has been received by the Company.

DISQUALIFICATIONS OF DIRECTORS

Pursuant to Section 164 of the Companies Act, 2013, no director has incurred any disqualification on account of non-compliance with any of the provisions of the Act.

DISCLOSURE ON VIGIL MECHANISM / WHISTLE BLOWER POLICY

The Company has established a Vigil Mechanism/Whistle blower Policy as a part of its vigil mechanism. The purpose of this Policy is to enable any person including the directors, employees, other stakeholders, etc. to raise concerns regarding unacceptable and improper practices and/or any unethical practices in the organization without the knowledge of the management.

All employees shall be protected from any adverse action for reporting any unacceptable or improper practice and/or any unethical practice, fraud or violation of any law, rule or regulation, potential or actual violation, leakage of unpublished price sensitive information without fear of reprisal.

The Company believes in the conduct of its affairs and its constituents by adopting the highest standards of professionalism, honesty, integrity, and ethical behavior, in line with the Code of Conduct (‘Code'). All the stakeholders are encouraged to raise their concerns or make disclosures on being aware of any potential or actual violation of the Code, policies or the law. Periodic awareness sessions are also conducted for the same. The Board has formulated policy on Vigil Mechanism/ Whistle blower Policy and the same may be accessed at the website of the Company.

MANAGEMENT DISCUSSION & ANALYSIS

Management Discussion and Analysis Report, as stipulated under the Listing Regulations is presented in a separate Section forming part of this Annual Report as "Annexure - A"

CORPORATE GOVERNANCE

In compliance with Regulation 34 of the Listing Regulations, a separate report on Corporate Governance along with a certificate from the Auditors on its compliance forms an integral part of this report as "Annexure B"

A certificate from the Practising Company Secretary confirming compliance of conditions of Corporate Governance as stipulated in Part E of the Schedule V of the Listing Regulations is annexed to the Corporate Governance Report.

STATUTORY AUDITORS:

M/s Gupta Rustagi & Co, Chartered Accountants were appointed as statutory auditors of the Company w.e.f. March 28, 2024 to fill the Casual Vacancy till the conclusion of 32nd Annual General Meeting i.e 30th September, 2024.

In 32nd Annual General Meeting, M/s Chandabhoy & Jassoobhoy, Chartered Accountants, as the Statutory Auditors of the Company for term of five consecutive years, who shall hold

office from the conclusion of this 32nd Annual General Meeting till the conclusion of the 37th Annual General Meeting to be held in the financial year 2028-29.

Further, the Notes to Accounts referred to in the Auditors' Report are self-explanatory and therefore do not call for any further comments. The Auditors' report does not contain any qualification, reservation or adverse remark.

SECRETARIAL AUDITOR

As per the Provisions of Section 204(1) read with Rule 9 of The Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014, your Company has been carrying out audit of its secretarial records.

Vishakha Agrawal & Associates, Company Secretary in practice had been appointed as Secretarial Auditor to conduct the Secretarial Audit of the Company for the Financial Year 2024-25

The Secretarial Audit Report in Form MR-3 obtained from Vishakha Agrawal & Associates, for the said financial year is annexed herewith and forms part of this report as "Annexure C".

The secretarial report is self-explanatory and any observation, qualification are duly responded by the Company within the timeframe.

SHIFTING OF REGISTERED OFFICE

During the year under review, the Company has not shifted its registered office.

LISTING FEE OF SHARES

The shares of the company are listed on a recognized stock exchange- ‘Bombay Stock Exchange' and up to date Listing Fee is paid.

DISCLOSURE UNDER SECTION 148 OF COMPANIES ACT, 2013:

Company is not required to maintain the cost records and accounts as specified under section 148 of Companies Act, 2013 as it not applicable on the Company.

CODE FOR PREVENTION OF INSIDER TRADING PRACTICES

In compliance with SEBI's regulations on Prevention of Insider Trading, the Company has instituted a comprehensive Code of Conduct for its Directors and Designated Employees. The code lays down guidelines which advise them on procedure to be followed and disclosures to be made while dealing with shares of the Company and cautioning them of consequences of violations.

Based on the recent amendments in the SEBI (Prevention of Insider Trading Regulations), 2015, the company has revised the "Code of Conduct for Prevention of Insider Trading" of the Company. Company Secretary is the Compliance Officer for the purpose of this code. During the year, there has been due compliance with the code by the Company and all insiders and requisite disclosures were made to the Stock Exchanges from time to time.

The Company has now adopted the new amended SEBI's (Prevention of Insider Trading) Regulations, 2015 duly approved by the Board of Directors at its meeting in term of which the Code of Practices Procedure for fair disclosure unpublished price sensitive information and the Code of Internal procedure and conduct for regulation, monitor and report of trading in the Securities for the designated employees and the connected persons have been adopted.

POLICY ON DIRECTORS' APPOINTMENT AND POLICY ON REMUNERATION

Pursuant to the provisions of Section 134 (3) (e) and Section 178 of the Companies Act, 2013 and in terms of Regulation 19(4) of the SEBI (Listing Obligation and Disclosure Requirement) Regulations, 2015, the Board has formulated a policy on Nomination and Remuneration for its Directors, Key Managerial Personnel and senior management.

The salient features of the Policy are:

• It provides the diversity on the Board of the Company and

• It provides the mechanism for performance evaluation of the Directors

• It lays down the parameters based on which payment of remuneration (including sitting fees and remuneration) should be made to Independent Directors and Non-Executive Directors.

• It lays down the parameters based on which remuneration (including fixed salary, benefits and perquisites, bonus/ performance linked incentive, commission, retirement benefits) should be given to Whole-time Directors, KMPs and rest of the employees.

It lays down the parameters for remuneration payable to Director for services rendered in other capacity.

It is hereby affirmed that the Remuneration paid is as per the Remuneration Policy of the Company. During the year under review, there were no substantive changes in the Policy except to align the Policy with amendments made to applicable laws.

SECRETARIAL STANDARD OF ICSI

The Company has complied with the Secretarial Standard-1 on ‘Meetings of the Board of Directors' and Secretarial Standard-2 on ‘General Meetings' issued by the Institute of Company Secretaries of India.

TRANSFER OF UNCLAIMED DIVIDEND AND UNCLAIMED SHARES

In terms of the provisions of Investor Education and Protection Fund (Accounting, Audit, Transfer and Refund) Rules, 2016 (including amendments and modifications, thereof), no unpaid/unclaimed dividends were transferred during the year under review to the Investor Education and Protection Fund.

For and on behalf of the Board Welcure Drugs & Pharmaceuticals Limited
Sd/- Sd/-
Place: New Delhi Date: 02.09.2025 Chintan Didawala Ganpat Managing Director DIN:11088268 Ravi Thakor Director DIN:11210729